162 related articles for article (PubMed ID: 29653961)
1. Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of
Yan D; Hamed O; Joshi T; Mostafa MM; Jamieson KC; Joshi R; Newton R; Giembycz MA
J Pharmacol Exp Ther; 2018 Jul; 366(1):220-236. PubMed ID: 29653961
[TBL] [Abstract][Full Text] [Related]
2. Impact of Phosphodiesterase 4 Inhibition on the Operational Efficacy, Response Maxima, and Kinetics of Indacaterol-Induced Gene Expression Changes in BEAS-2B Airway Epithelial Cells: A Global Transcriptomic Analysis.
Joshi R; Yan D; Hamed O; Mostafa MM; Joshi T; Newton R; Giembycz MA
Mol Pharmacol; 2019 Jul; 96(1):56-72. PubMed ID: 31036559
[TBL] [Abstract][Full Text] [Related]
3. GS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial Cells.
Joshi T; Yan D; Hamed O; Tannheimer SL; Phillips GB; Wright CD; Kim M; Salmon M; Newton R; Giembycz MA
J Pharmacol Exp Ther; 2017 Feb; 360(2):324-340. PubMed ID: 27927912
[TBL] [Abstract][Full Text] [Related]
4. The long-acting β2 -adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner.
Joshi T; Johnson M; Newton R; Giembycz MA
Br J Pharmacol; 2015 May; 172(10):2634-53. PubMed ID: 25598440
[TBL] [Abstract][Full Text] [Related]
5. Long-acting beta 2 agonists suppress IP-10 expression in human bronchial epithelial cells.
Chien JW; Chu YT; Yang SN; Kuo CH; Wang WL; Kuo PL; Jong YJ; Hung CH
J Investig Med; 2012 Oct; 60(7):1048-53. PubMed ID: 22914602
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome-Level Interactions between Budesonide and Formoterol Provide Insight into the Mechanism of Action of Inhaled Corticosteroid/Long-Acting
Mostafa MM; Rider CF; Wathugala ND; Leigh R; Giembycz MA; Newton R
Mol Pharmacol; 2021 Mar; 99(3):197-216. PubMed ID: 33376135
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.
Cazzola M; Calzetta L; Puxeddu E; Ora J; Facciolo F; Rogliani P; Matera MG
Respir Res; 2016 Jun; 17(1):70. PubMed ID: 27296533
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo preclinical profile of abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, compared with indacaterol, olodaterol and vilanterol.
Aparici M; Gavaldà A; Ramos I; Carcasona C; Otal R; Fernández-Blanco JA; Montero JL; García VM; López R; De Alba J; Doe C; Puig C; Vilella D; Miralpeix M
Eur J Pharmacol; 2016 Jan; 770():61-9. PubMed ID: 26656755
[TBL] [Abstract][Full Text] [Related]
9.
Hamed O; Joshi R; Michi AN; Kooi C; Giembycz MA
Mol Pharmacol; 2021 Oct; 100(4):388-405. PubMed ID: 34341099
[TBL] [Abstract][Full Text] [Related]
10. Agonist-induced β2-adrenoceptor desensitization and downregulation enhance pro-inflammatory cytokine release in human bronchial epithelial cells.
Oehme S; Mittag A; Schrödl W; Tarnok A; Nieber K; Abraham G
Pulm Pharmacol Ther; 2015 Feb; 30():110-20. PubMed ID: 24915152
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic characterization of indacaterol, a novel beta 2-adrenoceptor agonist.
Sayers I; Hawley J; Stewart CE; Billington CK; Henry A; Leighton-Davies JR; Charlton SJ; Hall IP
Br J Pharmacol; 2009 Sep; 158(1):277-86. PubMed ID: 19422388
[TBL] [Abstract][Full Text] [Related]
12. Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi.
Naline E; Trifilieff A; Fairhurst RA; Advenier C; Molimard M
Eur Respir J; 2007 Mar; 29(3):575-81. PubMed ID: 17135231
[TBL] [Abstract][Full Text] [Related]
13. α and β catalytic subunits of cAMP-dependent protein kinase regulate formoterol-induced inflammatory gene expression changes in human bronchial epithelial cells.
Hamed O; Joshi R; Mostafa MM; Giembycz MA
Br J Pharmacol; 2022 Sep; 179(18):4593-4614. PubMed ID: 35735057
[TBL] [Abstract][Full Text] [Related]
14. Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells.
Kaur M; Chivers JE; Giembycz MA; Newton R
Mol Pharmacol; 2008 Jan; 73(1):203-14. PubMed ID: 17901197
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
Battram C; Charlton SJ; Cuenoud B; Dowling MR; Fairhurst RA; Farr D; Fozard JR; Leighton-Davies JR; Lewis CA; McEvoy L; Turner RJ; Trifilieff A
J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
[TBL] [Abstract][Full Text] [Related]
16. Effects of (a Combination of) the Beta
Maarsingh H; Oldenburger A; Han B; Zuidhof AB; Elzinga CRS; Timens W; Meurs H; Sopi RB; Schmidt M
Cells; 2021 May; 10(5):. PubMed ID: 34069899
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
Holden NS; Rider CF; Bell MJ; Velayudhan J; King EM; Kaur M; Salmon M; Giembycz MA; Newton R
Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350
[TBL] [Abstract][Full Text] [Related]
18. Real time analysis of β(2)-adrenoceptor-mediated signaling kinetics in human primary airway smooth muscle cells reveals both ligand and dose dependent differences.
Billington CK; Hall IP
Respir Res; 2011 Jul; 12(1):89. PubMed ID: 21722392
[TBL] [Abstract][Full Text] [Related]
19. Induction of regulator of G-protein signaling 2 expression by long-acting β2-adrenoceptor agonists and glucocorticoids in human airway epithelial cells.
Holden NS; George T; Rider CF; Chandrasekhar A; Shah S; Kaur M; Johnson M; Siderovski DP; Leigh R; Giembycz MA; Newton R
J Pharmacol Exp Ther; 2014 Jan; 348(1):12-24. PubMed ID: 24163441
[TBL] [Abstract][Full Text] [Related]
20. An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol.
Beattie D; Beer D; Bradley ME; Bruce I; Charlton SJ; Cuenoud BM; Fairhurst RA; Farr D; Fozard JR; Janus D; Rosethorne EM; Sandham DA; Sykes DA; Trifilieff A; Turner KL; Wissler E
Bioorg Med Chem Lett; 2012 Oct; 22(19):6280-5. PubMed ID: 22932315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
